Enzyme-linked immunosorbent assay for detection of immunoglobulin G antibodies to Escherichia coli Vero cytotoxin
coli O157 Vero cytotoxin type 2, phage type 2 was isolated from 23 human cases and environmental animal fecal samples.
(3.) Two outbreaks of Vero cytotoxin producing Escherichia coli O157 infection associated with farms.
Guidelines for the control of infection with Vero cytotoxin producing Escherichia coli (VTEC).
In a prospective, unmatched case-control study of sporadic Shiga toxin (Vero cytotoxin)-producing Escherichia coil O157 (STEC 0157) infection in England, exposure to the farming environment emerged strongly as a risk factor (adjusted odds ratio = 2.45; 95% confidence intervals = 1.49-4.02; p=0.0004) posing further challenges and opportunities for prevention.
Shiga toxin (Vero cytotoxin)-producing Escherichia coli O157 (STEC O157) is an important emerging pathogen worldwide, and the illness and death associated with infection are considerable (1).
Risk factors for and prevention of sporadic infections with Vero cytotoxin (shiga toxin) producing Escherichia coli O157.
Laboratories were asked to send all presumptive VTEC O157 isolates to the Laboratory of Enteric Pathogens, Central Public Health Laboratory, London, for confirmation, phage-typing, and Vero cytotoxin typing (8).
coli O157 isolate did not express Vero cytotoxin genes.
The incidence and sources of Vero cytotoxin producing Escherichia coli O157 in Wales and the English Borders [Ph.D.